| Identification | Back Directory | [Name]
(4S,7R,8S,9S,13Z,16S)-4,8-Bis-{[tert-butyl(dimethyl)silyl]oxy}-5,5,7,9,13-pentamethyl-16-[(E)-1-methyl-2-(2-methyl-1,3-thiazol-4-yl)ethenyl]oxocyclohexadec-13-ene-2,6-dione | [CAS]
189453-35-8 | [Synonyms]
[4S-[4R*,7S*,8R*,9R*,13Z,16R*(E)]]-4,8-Bis[[(1,1-diMethylethyl)diMethylsilyl]oxy]-
(4S,7R,8S,9S,13Z,16S)-4,8-Bis-{[tert-butyl(dimethyl)silyl]oxy}-5,5,7,9,13-pentamethyl-16-[(E)-1-methyl-2-(2-methyl-1,3-thiazol-4-yl)ethenyl]oxocyclohexadec-13-ene-2,6-dione | [Molecular Formula]
C39H69NO5SSi2 | [MOL File]
189453-35-8.mol | [Molecular Weight]
732.216 |
| Chemical Properties | Back Directory | [Appearance]
White Foam | [Boiling point ]
698.1±55.0 °C(Predicted) | [density ]
1.01±0.1 g/cm3(Predicted) | [solubility ]
Chloroform, Dichloromethane, Ethanol, Ethyl Acetate, Methanol, Toluene | [form ]
Foam | [pka]
2.56±0.10(Predicted) | [color ]
White |
| Hazard Information | Back Directory | [Chemical Properties]
White Foam | [Uses]
An intermediate in the synthesis of Epothilones. Epothilones are polyketide natural products that inhibit cancer cells by a mechanism similar to paclitaxel, and also are effective against paclitaxel-resistant tumours. Epothilone D is in phase I clinical testing of in patients with advanced solid tumours. Epothilone D is a cytotoxic macrolide that stabilises malignant cells' microtubules and arrests mitosis, a characteristic it shares with other epothilones. They bind to the same hepatic sites as does paclitaxel (Taxol) in a 1:1 stoichiometric ratio of a, b-tubulin heterodimers. |
|
| Company Name: |
Energy Chemical
|
| Tel: |
021-58432009 400-005-6266 |
| Website: |
http://www.energy-chemical.com |
| Company Name: |
Carbosynth
|
| Tel: |
+86 512 6260 5585 |
| Website: |
www.carbosynth.com |
|